cetylpyridinium chloride anhydrous has been researched along with Uveitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, M; Agrawal, R; Chan, A; Cheung, CY; Ding, J; Gupta, V; Kim, R; Luthra, S; Mahajan, S; Mishra, C; Munk, MR; Nivison-Smith, L; Rousselot, A; Sen, P; Suh, MH; Wei, X | 1 |
| Acharya, NR; Al-Dhibi, HA; Berlinberg, EJ; Chattopadhyay, A; Cugley, D; Ebert, CD; Gonzales, JA; Kanakath, A; Kelly, NK; Lim, LL; Murugan, SB; Porco, TC; Rathinam, SR; Suhler, EB; Thundikandy, R; Vedhanayaki, R | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Uveitis
| Article | Year |
|---|---|
Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index.
Topics: Choroid; Choroid Diseases; Ciliary Arteries; Health; Humans; Macular Degeneration; Tomography, Optical Coherence; Uveitis | 2020 |
1 trial(s) available for cetylpyridinium chloride anhydrous and Uveitis
| Article | Year |
|---|---|
Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis.
Topics: Administration, Oral; Adult; Aged; Enzyme Inhibitors; Female; Health; Health Status; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Uveitis; Vision, Ocular | 2021 |